| Stephanie B J Emery, MD | |
|
1046 6th Avenue Sw, Albany, OR 97321-1916 | |
| (541) 812-4000 | |
| Not Available |
| Full Name | Stephanie B J Emery |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 1046 6th Avenue Sw, Albany, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295705937 | NPI | - | NPPES |
| 134177 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD22051 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Albany General Hospital | Albany, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany General Hospital | 9931097987 | 162 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20031111000297 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Good Samaritan Hospital Corvallis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Samaritan North Lincoln Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306897491 PECOS PAC ID: 7911816301 Enrollment ID: O20040120000329 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174888010 PECOS PAC ID: 2466353529 Enrollment ID: O20040204000304 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Samaritan North Lincoln Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306897491 PECOS PAC ID: 7911816301 Enrollment ID: O20061104000117 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20061104000140 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1801847066 PECOS PAC ID: 2466353529 Enrollment ID: O20061104000163 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie B J Emery, MD Po Box 1188, Corvallis, OR 97339-1188 Ph: (541) 812-4000 | Stephanie B J Emery, MD 1046 6th Avenue Sw, Albany, OR 97321-1916 Ph: (541) 812-4000 |
News Archive
The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.
Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.
Most smartphones and other electrical or electronic products contain small amounts of lead, which doesn't sound like a big problem on its own. But when there are many billions of such products, either in daily use or gone astray, the total sums up to very large amounts of lead - which is a toxic heavy metal.
Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology.
› Verified 9 days ago
Anthony Tran, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3420 24th Ct Se, Albany, OR 97322 Phone: 801-635-5514 | |
Andrew P Armstrong, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 | |
Dr. Thomas F. Clark, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1086 7th Ave Sw, Suite 101, Albany, OR 97321 Phone: 541-928-4249 Fax: 541-928-2942 | |
Mychall Raymond Columna Pagulayan-sy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 Hickory St Nw Ste 300, Albany, OR 97321 Phone: 541-812-5700 | |
Katrina G Hoffman, FNP Internal Medicine Medicare: Medicare Enrolled Practice Location: 4600 Evergreen Pl Se, Albany, OR 97322 Phone: 541-812-4662 Fax: 541-812-4660 | |
Mythili Raghavan Ransdell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Hickory St Nw Ste 300, Albany, OR 97321 Phone: 541-812-5700 | |
Dr. Daniel D. Mulkey, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1086 7th Ave Sw, Suite 101, Albany, OR 97321 Phone: 541-926-0393 Fax: 541-928-2942 |